62 employees
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
2003
$17M
from 1 investors over 1 rounds
Mapp Biopharmaceutical Inc raised $17M on June 23, 2019
Investors: U.S. Department of Health and Human Services (HHS)